Vedtægter for Genmab A/S

October 28, 2011 09:45 ET | Source: Genmab A/S Genmab A/S

Se venligst vedhæftede dokument for at læse Genmabs vedtægter.

Attachments

...

Recommended Reading

January 29, 2026 12:49 ET | Source: Genmab A/S

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Company Announcement COPENHAGEN, Denmark; January 29, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 32,806 restricted stock units and 34,307 warrants...
Read More
January 21, 2026 06:23 ET | Source: Genmab A/S

Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025

Company Announcement Net sales of DARZALEX® in 2025 totaled USD 14,351 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.)...
Read More